These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7552742)

  • 81. New antithrombin-based anticoagulants.
    Desai UR
    Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ; Santos GR; Mourão PA
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Recent advances in serine protease inhibitors as anticoagulant agents.
    Prezelj A; Anderluh PS; Peternel L; Urleb U
    Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A regular fucan sulfate from Stichopus herrmanni and its peroxide depolymerization: Structure and anticoagulant activity.
    Li X; Li S; Liu J; Lin L; Sun H; Yang W; Cai Y; Gao N; Zhou L; Qin H; Yin R; Zhao J
    Carbohydr Polym; 2021 Mar; 256():117513. PubMed ID: 33483034
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antithrombin III-mediated blood coagulation inhibitory activity of chitosan sulfate derivatized with different functional groups.
    Chandika P; Heo SY; Oh GW; Choi IW; Park WS; Jung WK
    Int J Biol Macromol; 2020 Oct; 161():1552-1558. PubMed ID: 32791278
    [TBL] [Abstract][Full Text] [Related]  

  • 87. First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa.
    Verghese J; Liang A; Sidhu PP; Hindle M; Zhou Q; Desai UR
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4126-9. PubMed ID: 19540113
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases.
    Henry BL; Thakkar JN; Liang A; Desai UR
    Biochem Biophys Res Commun; 2012 Jan; 417(1):382-6. PubMed ID: 22155248
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Coagulation factor Xa: the prothrombinase complex as an emerging therapeutic target for small molecule inhibitors.
    Scarborough RM
    J Enzyme Inhib; 1998; 14(1):15-25. PubMed ID: 10520757
    [No Abstract]   [Full Text] [Related]  

  • 90. Coagulation factors and their inhibitors.
    Stubbs MT; Bode W
    Curr Opin Struct Biol; 1994 Dec; 4(6):823-32. PubMed ID: 7712286
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Control of Heparanase Through the Use of Small Molecules.
    Giannini G; Battistuzzi G; Rivara S
    Adv Exp Med Biol; 2020; 1221():567-603. PubMed ID: 32274727
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Immobilization of heparin: approaches and applications.
    Murugesan S; Xie J; Linhardt RJ
    Curr Top Med Chem; 2008; 8(2):80-100. PubMed ID: 18289079
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dynamic Combinatorial Optimization of
    Carbajo D; Pérez Y; Guerra-Rebollo M; Prats E; Bujons J; Alfonso I
    J Med Chem; 2022 Mar; 65(6):4865-4877. PubMed ID: 35235323
    [TBL] [Abstract][Full Text] [Related]  

  • 94. De novo design of self-assembling foldamers that inhibit heparin-protein interactions.
    Montalvo GL; Zhang Y; Young TM; Costanzo MJ; Freeman KB; Wang J; Clements DJ; Magavern E; Kavash RW; Scott RW; Liu D; Degrado WF
    ACS Chem Biol; 2014 Apr; 9(4):967-75. PubMed ID: 24491145
    [TBL] [Abstract][Full Text] [Related]  

  • 95. New developments in the characterization of heparin and its impurities.
    Larive CK
    Anal Bioanal Chem; 2011 Jan; 399(2):525-6. PubMed ID: 21116617
    [No Abstract]   [Full Text] [Related]  

  • 96. Four new fatty acid esters from the Feces of Trogopterus xanthipes.
    Yang NY; Tao WW; Duan JA; Guo JM; Cao LL
    Lipids; 2009 Sep; 44(9):849-53. PubMed ID: 19649668
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Advances in the preparation and synthesis of heparin and related products.
    Baytas SN; Linhardt RJ
    Drug Discov Today; 2020 Dec; 25(12):2095-2109. PubMed ID: 32947045
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Glycoarray Technologies: Deciphering Interactions from Proteins to Live Cell Responses.
    Puvirajesinghe TM; Turnbull JE
    Microarrays (Basel); 2016 Jan; 5(1):. PubMed ID: 27600069
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates.
    Puvirajesinghe TM; Turnbull JE
    Metabolites; 2012 Nov; 2(4):1060-89. PubMed ID: 24957775
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.